8-K: GeneDx Reports Second Quarter 2024 Financial Results and Business Highlights
8-K: Current report
8-K: Current report
DEFA14A: Others
DEF 14A: Definitive information statements
8-K: GeneDx Reports First Quarter 2024 Financial Results and Business Highlights
GeneDx Holdings | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
GeneDx Holdings | 8-K: GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024
GeneDx Holdings | 8-K: Current report
GeneDx Holdings | 8-K: GeneDx Reports Third Quarter 2023 Financial Results and Business Highlights
GeneDx Holdings | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
GeneDx Holdings | 8-K: GeneDx Reports Second Quarter 2023 Financial Results and Business Highlights
GeneDx Holdings | 8-K: Current report
GeneDx Holdings | 8-K: Current report
GeneDx Holdings | DEFA14A: Others
GeneDx Holdings | 8-K: Current report
GeneDx Holdings | 8-K: GeneDx Reports First Quarter 2023 Financial Results and Business Highlights
GeneDx Holdings | DEF 14A: Definitive proxy statements
GeneDx Holdings | 8-K: Current report
GeneDx Holdings | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
No Data
No Data